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Aims. Diabetic patients with coronary artery disease (CAD) are often free of chest pain
syndrome. A useful modality for non-invasive assessment of CAD is coronary computed
tomography angiography (CTA). However, the prognostic value of CAD on coronary CTA in
diabetic patients without chest pain syndrome is relatively unknown. Therefore, the aim was to
investigate the long-term prognostic value of coronary CTA in a large population diabetic
patients without chest pain syndrome.
Methods. Between 2005 and 2013, 525 diabetic patients without chest pain syndrome were
prospectively included to undergo coronary artery calcium (CAC)-scoring followed by coro-
nary CTA. During follow-up, the composite endpoint of all-cause mortality, non-fatal
myocardial infarction (MI), and late revascularization (>90 days) was registered.
Results. In total, CAC-scoring was performed in 410 patients and coronary CTA in 444
patients (431 interpretable). After median follow-up of 5.0 (IQR 2.7-6.5) years, the composite
endpoint occurred in 65 (14%) patients. Coronary CTA demonstrated a high prevalence of
CAD (85%), mostly non-obstructive CAD (51%). Furthermore, patients with a normal CTA
had an excellent prognosis (event-rate 3%). An incremental increase in event-rate was observed
with increasing CAC-risk category or coronary stenosis severity. Finally, obstructive (50-70%)
or severe CAD (>70%) was independently predictive of events (HR 11.10 [2.52;48.79]
(P 5 .001), HR 15.16 [3.01;76.36] (P 5 .001)). Obstructive (50-70%) or severe CAD (>70%)
provided increased value over baseline risk factors.
Conclusion. Coronary CTA provided prognostic value in diabetic patients without chest
pain syndrome. Most importantly, the prognosis of patients with a normal CTA was excellent.
(J Nucl Cardiol 2016;23:24–36.)
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CABG Coronary artery bypass grafting
CAC Coronary artery calcium
CAD Coronary artery disease
CTA Computed tomography angiography
DM Diabetes mellitus
ESC European Society of Cardiology
MI Myocardial infarction
PCI Percutaneous coronary intervention
See related editorial, pp. 37–41
INTRODUCTION
Diabetesmellitus (DM) is amajor and rapidly growing
global health problem. In 2013, DM was responsible for
8.4% of all-cause mortality in patients between 20 and
79 years old and 10.8% of total health expenditure world-
wide.1 Cardiovascular complications are the leading cause
of mortality in diabetic patients.2 Accordingly, the Euro-
pean Society of Cardiology (ESC) classifies patients with
DM as high risk for coronary artery disease (CAD).3
However, not all patients with DM have CAD and also
diabetic patients with CAD are often free of chest pain
syndrome.4 Coronary computed tomography angiography
(CTA) is a useful modality for non-invasive assessment of
CAD. Indeed, in diabetic patients without chest pain
syndrome, a highprevalenceofCADispresent on coronary
CTA.5-7 Potentially CTA could be used to risk stratify DM
patients. However, the prognostic value of CAD on
coronary CTA in these patients is relatively unknown. As
a consequence, the value of coronary CTA for risk
stratification of these patients is unestablished.8,9 There-
fore, the aim of this study is to investigate the long-term
prognostic value of coronary CTA in a large population of
diabetic patients without chest pain syndrome.
METHODS
Patients
The study population consisted of 525 diabetic patients
without chest pain syndrome, referred from an outpatient
diabetic clinic for assessment of cardiovascular risk between
May 2005 and August 2013. The cardiovascular assessment
includes coronary artery calcium (CAC) score and CTA to
evaluate the presence and severity of CAD.5,10 After enrolment
in the prospective clinical registry, patients underwent a non-
contrast CT for CAC-scoring followed by a contrast coronary
CTA. Inclusion criteria consisted of confirmed diagnosis of
DM type 1 or 2 (fasting plasma glucose level C126 mg/dL, use
of oral glucose lowering medication or insulin) and the
absence of chest pain syndrome.11 Exclusion criteria were
known or suspected (CAD), previous coronary revasculariza-
tion, cardiac arrhythmias, pregnancy, and contraindications for
the use of iodinated contrast media.
Clinical data were prospectively entered into the depart-
mental Cardiology Information System (EPD-Vision, Leiden
University Medical Center, the Netherlands) and retrospectively
analyzed. The Institutional Review Board of the Leiden Univer-
sity Medical Center approved this evaluation of clinically
collected data, andwaived the need forwritten informed consent.
Coronary CTA Acquisition
Patients were scanned using a 64-slice or 320-row
multidetector scanner (64-slice: Aquillon 64, Toshiba Medical
Systems, Otawara, Japan; 320-row: Aquillon ONE, Toshiba
Medical System, Otawara, Japan). Scan-protocol was followed
as previously described.12,13 Post-processing of scans was
performed with application of dedicated software (Vitrea FX
1.0, Vital Images, Minnetonka, MN, USA). Uninterpretable
scans were excluded from the analysis.
CAC-Scoring
CAC-scoring was performed according to the algorithm
of Agatston. CAC-score was stratified into four risk categories:
0, 1-99, 100-399, C400.12
Coronary CTA
All coronary CTAs were analyzed by consensus of
experienced observers according to the modified 17 segments
American Heart Association (AHA) classification.
First, each segment was assessed for interpretability. Seg-
ments were defined as uninterpretable in case of severe motion
artefacts or low-contrast resolution. Additionally, segments with
a diameter B1.5 mm were excluded.5 Second, interpretable
segments were evaluated for stenosis. Stenosis was stratified into
four categories: normal if no plaques were present on CTA, non-
obstructive if the plaque covered\50%, obstructive if the plaque
covered 50-70%, severe if the plaque covered[70% of the
coronary artery lumen. If plaquewas present, plaque composition
was determined (calcified,mixed, andnon-calcified).One type of
plaque compositions was assigned per segment.
Follow-Up
Follow-up data were retrospectively gathered by review of
electronic medical records; blinded from CTA results, between
December 2013 and February 2014, both the medical records of
the department of cardiology and of the referring outpatient
diabetic clinic have been analyzed. Three endpoints were
registered: all-cause mortality, non-fatal myocardial infarction
(MI), late revascularization. Non-fatal MI was defined based on
criteria of typical chest pain, elevated cardiac enzyme levels, and
typical changes on the ECG.14 Late revascularization was
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defined as percutaneous coronary intervention (PCI) or coronary
artery bypass grafting (CABG) after 90 days of scan acquisi-
tion.15 All revascularization procedures within 90 days were
considered coronary CTA-driven. For the analysis, a composite
endpoint was constructed of all three endpoints.
Statistical Analysis
All continuous data (normally distributed, non-normally
distributed) are presented as mean ± SD for reasons of
uniformity. Categorical data are presented as absolute numbers
and percentages.
First, baseline characteristics were compared between
patients with and without obstructive CAD (C50%), similarly
between patients with and without events. Second, results of
both CAC-scoring and coronary CTA were compared between
patients with and without events. Third, survival analyses were
performed by the Kaplan-Meier method. Cumulative event-
rates for CAC-score and coronary stenosis were obtained by
this method, using the composite endpoint. Note that these
survival analyses were crude, because no corrections for
baseline characteristics were performed. Fourth, the indepen-
dent prognostic value of baseline characteristics, CAC-scoring,
and coronary CTA was assessed. For this purpose, univariate
and multivariate Cox-regression analyses were performed. To
avoid over fitting of the model, a selection of univariate
significant variables was entered into the multivariate model.
All statistical tests were two-sided. Comparisons between
groups were performed with the Independent-Samples T test or
Mann-Whitney U test for continuous data and the v2 test for
categorical data. Comparisons of Kaplan-Meier curves were
performed with the Log-Rank test. To compare the model fit of
themultivariate Cox-regressionmodels for CTAandCAC-score
the -2 Log Likelihood was used. However, it should be noted
that for non-nested models (i.e., Model 2 vs. Model 4), this only
provides a crude comparison for which no P values could be
calculated. All statistical analyses were performed with SPSS
software (Version 22.0, SPSS IBM Corp., Armonk, New York).
A P value\.05 was considered statistically significant.
RESULTS
Patients
The study population consisted of 525 patients. As
depicted in Figure 1, 76 (14%) patients were excluded
from this analysis because of logistical reasons (i.e.,
patients who did not attend appointment). The results of
449 patients were available for the present analysis: 405
patients underwent both CAC-scoring and coronary
CTA; 5 patients underwent only CAC-scoring; 39
patients underwent only coronary CTA. In total, CAC-
scoring was performed in 410 patients and coronary
CTA in 444 patients. Mean age was 54 ± 11 years; 265
(59%) patients were male, and median DM duration was
12 (IQR 6-22) years. Baseline characteristics of the
population are depicted in Table 1.
Events
The composite endpoint of all-cause mortality, non-
fatal MI, and late revascularization occurred in 65 (14%)
patients. All-cause mortality occurred in 13 (3%)
Included 
n=525 




Only coronary CTA 
n=39 
Both CAC-score + coronary CTA  
n=405 
No scans performed 
 because of logiscal reasons 
n=76 
Figure 1. Flowchart of the study population.
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patients and late revascularization in 52 (12%) patients
(PCI: 30 patients, CABG: 22 patients). Of the 52
patients who underwent revascularization, 27 (52%)
patients were referred to invasive coronary angiography
because of new-onset angina, 20 (38%) patients had
documented ischemia on a single positron emission
tomography (SPECT) myocardial perfusion imaging
(MPI) performed after CTA, and 5 (10%) patients
presented with new ischemia on SPECT MPI during
follow-up. Non-fatal MI did not occur. Early revascu-
larization, which was excluded from the composite
endpoint, occurred in 16 (4%) patients (PCI: 13 patients,
CABG: 3 patients). Median follow-up was 5.0 (IQR
2.7-6.5) years. No patients were lost to follow-up.
Patients with events demonstrated a higher mean
age [59 ± 10 vs. 53 ± 11 (P\ .001)] and number of
males [47 (72%) vs. 218 (57%) (P = .018)] compared to
patients without events. Furthermore, hypercholes-
terolemia [33 (51%) vs. 129 (34%) (P = .009)],
smoker [23 (35%) vs. 78 (21%) (P = .008)], and overall
DM-related complications (P = .002) were more fre-
quently observed in this group (Table 1).
CAC-Scoring
CAC-scoring was performed in 410 patients. Median
CAC-score was 29 (IQR 0-294). The distribution within
the CAC-risk categories was as follows: CAC-score = 0
in 144 (35%) patients, CAC-score = 1-99 in 106 (26%)
patients, CAC-score = 100-399 in 67 (16%) patients,
CAC-score C 400 in 93 (23%) patients. In total, CAC-
score = 0 and CAC-score C 1 were observed in respec-
tively 35% and 65% of patients (Table 2).
The results of CAC-scoring, stratified according to
events, are depicted in Table 2. Patients with events
demonstrated a higher median CAC-score compared to
patients without events [543 (IQR 141-1310) vs. 13
(IQR 0-177) (P\ .001)]. Moreover, patients with events
were more often classified in a higher CAC-risk cate-
gory (P\ .001).
Coronary CTA
Coronary CTA was performed in 444 patients, of
which 13 were uninterpretable. The remaining results of
431 patients were used for the present analysis. A high
prevalence of CAD (85%) was demonstrated on coronary
CTA: non-obstructive CAD (\50%) in 219 (51%)
patients, obstructive CAD (50-70%) in 117 (27%)
patients, severe CAD ([70%) in 30 (7%) patients. A
normal CTAwas observed in 65 (15%) patients (Table 2).
The baseline characteristics, stratified according to
coronary CTA results, are depicted in Table 1. Patients
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mean age [60 ± 9 vs. 50 ± 11 (P\ .001)], number of
males [101 (69%) vs. 154 (54%) (P = .004)], and
median diabetes duration [15 (IQR 9-24) vs. 10 (IQR
5-20) (P\ .001)) compared to patients with no or non-
obstructive CAD (\50%). Furthermore, hypertension
[65 (44%) vs. 72 (26%) (P\ .001)], hypercholes-
terolemia [68 (46%) vs. 85 (30%) (P = .001)], and
overall DM-related complications (P\ .001) were more
frequently observed in this group.
The results of coronary CTA, stratified according to
events, are depicted in Table 2. Patients with events
presented with more severe coronary stenosis compared
to patients without events (P\ .001). Moreover, a
higher mean number of plaques [9.7 ± 4.4 vs. 7.7 ± 5.7
(P = .002)], mean number of obstructive lesions
[2.8 ± 2.8 vs. 0.6 ± 1.4 (P\ .001)], and mean number
of severe lesions [0.3 ± 0.8 vs. 0.1 ± 0.4 (P = .009)]
were observed in this group. In addition, a higher mean
number of calcified lesions [2.6 ± 3.5 vs. 0.8 ± 1.8
(P\ .001)] and mixed lesions [3.0 ± 3.0 vs. 1.3 ± 2.1
(P\ .001)] were present in patients with events.
Kaplan-Meier Analysis
The results of the Kaplan-Meier survival analyses,
stratified according to CAC-score, are depicted in
Figure 2A and B. Crude event-rate was lower in patients
with CAC-score = 0 compared to patients with CAC-
score C 1 [5/144 (3%) vs. 54/266 (20%) (P\ .001)] (A).
Additionally, an incremental increase in event-rate was
observed with increasing CAC-risk category: 5/144 (3%)
for CAC-score = 0, 7/106 (7%) for CAC-score = 1-99,
12/67 (18%) for CAC-score = 100-399, 35/93 (38%) for
CAC-score C 400 (P\ .001). Thus, event-rate was
highest in patients with CAC-score C 400 (B).
The results of the Kaplan-Meier survival analyses,
stratified according to coronary stenosis, are depicted in
Figure 2C and D. Crude event-rate was lower in patients








(n 5 351) P value








CAC-score = 0 144 (35%) 5 (9%) 139 (40%)
CAC-score = 1–99 106 (26%) 7 (12%) 99 (28%)
CAC-score = 100–399 67 (16%) 12 (20%) 55 (16%)








(n 5 367) P value
Coronary stenosis <.001
No. of patients with normal CTA n (%) 65 (15%) 2 (3%) 63 (17%)
No. of patients with non-obstructive CAD (\50%) n (%) 219 (51%) 11 (17%) 208 (57%)
No. of patients with obstructive CAD (50–70%) n (%) 117 (27%) 39 (61%) 78 (21%)
No. of patients with severe CAD ([70%) n (%) 30 (7%) 12 (19%) 18 (5%)
Coronary plaques (stenosis)
No. of plaques 8.0 ± 5.6 9.7 ± 4.4 7.7 ± 5.7 .002
No. of non-obstructive lesions 7.0 ± 5.3 6.9 ± 4.1 7.1 ± 5.4 .724
No. of obstructive lesions 1.0 ± 1.9 2.8 ± 2.8 0.6 ± 1.4 \.001
No. of severe lesions 0.1 ± 0.5 0.3 ± 0.8 0.1 ± 0.4 .009
Coronary plaques (composition)
No. of calcified lesions 1.1 ± 2.2 2.6 ± 3.5 0.8 ± 1.8 <.001
No. of mixed lesions 1.5 ± 2.4 3.0 ± 3.0 1.3 ± 2.1 <.001
No. of non-calcified lesions 0.9 ± 1.5 1.3 ± 2.2 0.8 ± 1.4 .067
Bold values are statistically significant (P\0.05)
CAC, Coronary artery calcium; CAD, Coronary artery disease; CTA, Computed tomography coronary angiography
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with no or non-obstructive CAD (\50%) compared to
patients with obstructive CAD (C50%) [13/284 (5%) vs.
51/147 (35%) (P\ .001)] (C). An excellent prognosis
was observed in patients with a normal CTA [event-rate
2/65 (3%)]. Of note, the 2 patients with a normal CTA
presented with complications not related to diabetes and
died of a (presumably) non-cardiac course. Additionally,
an incremental increase in event-rate was observed with
increasing coronary stenosis severity: 11/219 (5%) for
non-obstructive CAD (\50%), 39/117 (33%) for
obstructive CAD (50-70%), 12/30 (40%) for severe
CAD ([70%) (P\ .001). Event-rate was highest in
patients with severe CAD ([70%) (D).
Cox-Regression Analysis
The results of univariate Cox-regression analyses for
the prediction of events are depicted in Tables 3 and 4.
CAC-score C 100, obstructive (50-70%) or severe CAD
([70%), total number of plaques, number of plaques
stratified to stenosis (obstructive, severe) and number of
plaques stratified to plaque composition (calcified, mixed,
non-calcified) were all significant univariate predictors of
the composite endpoint (Table 4).
The results of the multivariate Cox-regression
analyses for the prediction of events are depicted in
Table 5. To avoid over fitting of the model (limited
number of events, n = 65), only a selection of the
univariate significant variables was entered into the
multivariate model (i.e., age, male gender, smoker,
CAC-risk category, coronary stenosis grade). The vari-
able smoker was selected over hypertension and
hypercholesterolemia, assuming it correlated less with
age and male gender. Moreover, replacing smoking with
either hypertension or hypercholesterolemia did not
have a strong influence on the results. In the multivariate
analyses, corrected for the selected baseline variables
(Model 2), CAC-score C 100 was independently pre-
dictive of events. Moreover, CAC-score C 400 provided
incremental prognostic value over CAC-score = 100-
399 [HR 12.52 (95% CI 4.29; 36.54) (P\ .001) vs. HR
5.13 (95% CI 1.68; 15.60) (P = .004)]. Accordingly,
obstructive (50-70%) or severe CAD ([70%) remained
an independent predictor of events. The presence of
severe CAD ([70%) provided incremental prognostic
value over obstructive CAD (50-70%) [HR 15.16 (95%
CI 3.01; 76.36) (P = .001) vs. HR 11.10 (95% CI 2.52;
48.79) (P = .001)]. Adding the CTA results to Model 2
(including baseline variables and CAC-score) resulted in
a significant change in -2 Log Likelihood (17.60,
P = .001) (Model 3). Moreover, adding the CTA results
to the baseline model resulted in a larger increase in the
Figure 2. Kaplan-Meier curves for the composite endpoint (all-cause mortality, non-fatal MI, late revascularization) according to
CAC-score and coronary stenosis. (A) Event-free survival difference between patients with CAC-score = 0 and CAC-score C 1. (B)
event-free survival difference between patients with CAC-score = 0, CAC-score = 1-99, CAC-score = 100-399 and CAC-
score C 400. (C) event-free survival difference between patients with no or non-obstructive CAD (\50%) and obstructive CAD
(C50%). (D) event-free survival difference between patients with normal CTA, non-obstructive CAD (\50%), obstructive CAD (50-
70%) and severe CAD ([70%).
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-2 Log Likelihood compared to the adding of the CAC-
score (43.78 vs. 36.30) (Model 4).
DISCUSSION
The present study assessed the long-term prognostic
value of coronary CTA in a large prospective registry of
diabetic patients without chest pain syndrome. Coronary
CTA demonstrated high prevalence of CAD (85%),
mostly non-obstructive. Most importantly, patients with
a normal CTA had an excellent prognosis. Furthermore,
an incremental increase in event-rate was observed with
increasing coronary stenosis severity. Finally, obstructive
(50-70%) or severe CAD ([70%) was independently
predictive of events, with increased value over baseline
risk factors (i.e., age, male gender, smoker). Moreover,
the CAC-score demonstrated a similar independent
predictive value for the occurrence of events. However,
the model including CTA performed better than the
model with CAC-score. Besides, CTA provided some
additional value over the CAC-score. Nevertheless, it
should be noted that this was a crude analysis and that
the present study was not designed to assess the
difference in performance between CAC-score and
CTA.
CAC-Score
Previous studies widely established the prevalence
of CAC in diabetic patients without chest pain syn-
drome.16-18 The present study assessed the prognostic
value of CAC by demonstrating CAC-score C 100 as
independent predictor of events in diabetic patients
without chest pain syndrome. Prior to our study, Raggi
et al investigated the prognostic value of CAC-scoring
for all-cause mortality in asymptomatic individuals.19 In
this study, 10,377 asymptomatic individuals were
prospectively included to undergo electron beam com-
puted tomography (EBCT): 903 (9%) individuals with
DM, 9474 (91%) individuals without DM. This study,
with mean follow-up of 5 years, demonstrated CAC as
independent predictor of all-cause mortality in both
diabetic and non-diabetic asymptomatic individuals.
Moreover, Anand et al investigated the prognostic value
of EBCT for short-term events in 510 asymptomatic
patients with DM type 2.20 This study, with median
follow-up of 2.2 years, demonstrated CAC-score C 100
as independent predictor of cardiac death, MI, acute
coronary syndrome (ACS), late coronary revasculariza-
tion ([60 days after EBCT), and non-haemorrhagic
stroke over established cardiovascular risk factors.
Additionally, the PREDICT (prospective evaluation of
diabetic ischemic disease by computed tomography)
study investigated the prognostic value of EBCT for
cardiovascular events in 589 asymptomatic patients with
DM type 2.21 Cardiovascular events, which were defined
as death due to MI or other cardiovascular causes, non-
fatal MI, unstable angina, other objective evidence of
CAD, and stroke, occurred in 66 (11%) patients after
median follow-up of 4 years. In the multivariate anal-
yses, CAC-score C101 was independently predictive of
cardiovascular events. These findings were in line with
the present study. Moreover, similar to the present study,
incremental prognostic value was provided with increas-
ing CAC-risk category.
Table 3. Univariate Cox-regression analyses of




HR [95%CI] P value
Age 1.06 [1.04;1.09] <.001
Male 1.97 [1.14;3.38] .015
BMI 1.00 [0.96;1.04] .959
Hypertension 1.79 [1.10;2.93] .020
Hypercholesterolemia 2.15 [1.32;3.51] .002
Family history of CAD 0.95 [0.58;1.56] .846
Smoker 1.98 [1.19;3.30] .008
DM-related risk factors
DM type 2 1.58 [0.87;2.85] .132
DM duration 1.00 [1.00;1.00] .160
HbA1C 1.08 [0.92;1.27] .326
DM-related complications
PVD 3.01 [1.37:6.60] .006
PNP 1.66 [0.98;2.82] .058
PVD and PNP 1.77 [0.76;4.10] .184
DM-related treatment
Oral 1.13 [0.67;1.90] .646
Insulin 0.60 [0.35;1.04] .069
Oral and insulin 1.79 [1.06;3.01] .028
Medication
Aspirin 2.78 [1.69;4.55] <.001
ACE-inhibitors 2.39 [1.47;3.89] <.001
ARB 1.03 [0.44;2.39] .946
Statins 1.97 [1.16;3.34] .012
Beta-blockers 2.29 [1.20;4.39] .012
Calcium-antagonists 3.94 [1.70;9.14] .001
Serum markers
Total cholesterol 1.23 [0.99;1.54] .067
LDL 1.13 [0.89;1.43] .317
HDL 0.92 [0.55;1.54] .756
Cholesterol/HDL ratio 1.06 [0.93;1.22] .364
Triglycerides 1.09 [0.91;1.31] .364
Bold values are statistically significant (P\0.05)
Abbreviations and definitions as in Table 1
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Coronary Stenosis on CTA
Several large cohort studies assessed the prevalence
of CAD in the specific setting of diabetic patients
without chest pain syndrome.6,17,22,23 Similar to the
present study, in these studies, the majority of asymp-
tomatic diabetic patients presented with CAD on
coronary CTA (64-93%). Accordingly, non-obstructive
CAD (\50%) was most frequently observed (44-64%),
whereas obstructive CAD (C50%) was less prevalent
(17-29%).
Only a few studies assessed the prognostic value of
coronary CTA in diabetic patients without chest pain
syndrome.15,22,24 From the CONFIRM (coronary CT
angiography evaluation for clinical outcomes: an inter-
national multicentre) registry of 27,125 patients, Min
et al selected 400 asymptomatic diabetic patients who
underwent coronary CTA.15 The prognostic value of
CTA was investigated using the same composite end-
point as in the present study. Events occurred in 33 (8%)
patients after mean follow-up of 2.4 ± 1.1 years: all-
cause mortality in 13 (3%) patients, non-fatal MI in 8
(2%) patients, late revascularization in 12 (3%) patients.
In the multivariate analyses, corrected for selected
variables (i.e., age, male gender, CAC-score), maximal
stenosis severity, number of vessels with obstructive
CAD (C50%), and segment stenosis score (a marker of
overall atherosclerosis extent) were independently pre-
dictive of events. Indeed, obstructive (50-70%) or severe
([70%) CAD provided prognostic value in the present
study. Also Faustino et al investigated the prognostic
value of coronary CTA for cardiovascular events in 85
asymptomatic patients with DM type 2.24 Cardiovascu-
lar events occurred in 10 (11.8%) patients after median
follow-up of 48 (IQR 18-68) months: cardiovascular
death in 2 (2.4%) patients, unstable angina in 1 (1.2%)
patients, stroke 7 (8.4%) in patients. In the multivariate
analyses, corrected for univariate significant variables,
the absence of obstructive CAD (C50%) was indepen-
dently protective of events. Indeed, no or non-
obstructive CAD (\50%) was not associated with
increased risk for events in the present study. Most
importantly, patients with a normal CTA had an excel-
lent prognosis. Last, Park et al investigated the
prognostic value of coronary CTA for cardiovascular
events in 557 asymptomatic Korean patients with DM
type 2.22 Cardiovascular events were defined as
Table 4. Univariate Cox-regression analyses of CAC-scoring and coronary CTA for the prediction of
events
Univariate
HR [95%CI] P value
CAC-scoring
CAC-risk category Overall <.001
CAC-score = 0 Ref. category
CAC-score = 1–99 1.92 [0.61;6.05] .265
CAC-score = 100–399 6.11 [2.15;17.35] .001
CAC-score C 400 15.79 [6.16;40.50] <.001
Coronary CTA
Coronary stenosis Overall <.001
Normal CTA Ref. category
Non-obstructive CAD (\50%) 1.92 [0.43;8.67] .397
Obstructive CAD (50-70%) 16.18 [3.90;67.21] <.001
Severe CAD ([70%) 29.03 [6.40;131.73] <.001
Coronary plaques (stenosis)
No. of plaques 1.09 [1.04;1.14] <.001
No. of non-obstructive lesions 1.02 [0.98;1.07] .375
No. of obstructive lesions 1.40 [1.31;1.51] <.001
No. of severe lesions 2.42 [1.77;3.30] <.001
Coronary plaques (composition)
No. of calcified lesions 1.22 [1.14;1.30] <.001
No. of mixed lesions 1.24 [1.16;1.33] <.001
No. of non-calcified lesions 1.17 [1.04;1.31] .007
Bold values are statistically significant (P\0.05)
Abbreviations and definitions as in Table 2
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cardiovascular death, non-fatal MI, ACS requiring
hospitalization, and late revascularization ([6 months
after coronary CTA). More cardiovascular events and
lower 3 years event-free survival rates were observed in
patients with obstructive CAD (C50%) compared to
patients without obstructive CAD (\50%). Accordingly,
in the present study, a higher crude event-rate was
observed in patients with obstructive CAD (C50%)
compared to patients with no or non-obstructive CAD
(\50%).
Coronary Plaque Composition on CTA
Multiple studies assessed plaque composition on
coronary CTA in diabetic patients without chest pain
syndrome. Comparable to the present study, the majority
of these studies described an increased prevalence of
mixed lesions in asymptomatic diabetic patients.6,17,25
The prognostic value of coronary plaque composi-
tion on coronary CTA for cardiovascular events in the
specific setting of diabetic patients without chest pain
syndrome has not been previously established. The
present study demonstrated all coronary plaque compo-
sitions (calcified, mixed, non-calcified) as univariate
significant predictors of events. The prognostic value of
calcified and mixed lesions was highest. These findings
suggest an independent association between plaque
composition and events.
However, the role of coronary plaque composition
remains controversial. Gaemperli et al demonstrated the
prognostic value of coronary plaque composition in 220
symptomatic patients.26 In contrast to the present study,
mixed and non-calcified plaque provided the highest
predictive value for events. On the other hand, in the
CONFIRM registry, including both symptomatic and
asymptomatic patients with and without DM, calcified
and mixed plaque provided the strongest predictive
value.27 Further research is needed to understand the
underlying pathophysiological mechanism of the differ-
ent coronary plaque compositions.
SPECT Myocardial perfusion Imaging (MPI)
The role of SPECT MPI for screening for silent
ischemia in asymptomatic diabetic patients has been
previously addressed.20,28 Anand et al included 510
asymptomatic diabetic patients of whom 180 patients
underwent SPECT MPI.20 In those patients, the event-
rate was significantly increased with increasing ischemic
burden on SPECT MPI demonstrating the value for risk
stratification. The most important study in this field was
the DIAD (detection of Ischemia in Asymptomatic
Diabetics) study.28 In this randomized controlled
trial, 1123 asymptomatic diabetic participants were
randomized to SPECT MPI or no screening. After a
mean follow-up of 4.8 years, the incidence of cardiac
events was higher in patients with significant MPI
abnormalities. However, there was no significant prog-
nostic benefit of screening.
Clinical Implications
The present observations demonstrate the prog-
nostic value of CTA in diabetic patients without chest
pain syndrome. Recent ESC guidelines indicate
patients with DM as high risk for CAD (or very high
risk if C1 cardiovascular risk factor was present)
irrespective of chest pain symptoms. Indeed, in the
present study, a great majority of patients presented
with CAD on coronary CTA and the presence of
obstructive (50-70%) or severe CAD ([70%) was
associated with an impaired prognosis. Still, CAD was
ruled-out in 15% of patients based on a normal CTA.
Most importantly, the prognosis of these patients was
excellent.
The value of screening for CAD in high-risk
diabetic patients without chest pain syndrome was
recently addressed by Muhlestein et al.29 In this trial,
900 asymptomatic patients were randomized to CAD
screening using coronary CTA or optimal medical
treatment (OMT). The trial demonstrated no survival
benefit from screening with coronary CTA. Therefore,
this study does not support screening in all diabetic
patients. Similarly, the American Diabetes Association
position statement on cardiovascular disease and risk
management only recommend screening using advanced
cardiac testing in patients with cardiac symptoms or
ECG abnormalities.30 However, as also demonstrated in
the present study, a large proportion of the patients had
CAD on CTA and coronary CTA could identify patients
with excellent prognosis. This supports the need to
enrich the screening population to a high-risk population
who will mostly benefit from screening using coronary
CTA. Especially since coronary CTA may lead to
radiation exposure and may result in unnecessary
invasive testings such as coronary angiography and
revascularization procedures.30 Potentially, coronary
CTA can provide a pivotal role in tailored therapy in
these diabetic patients. Patients with a normal CTA have
an excellent prognosis and could be treated conserva-
tively (OMT), whereas patients with an abnormal CTA
may benefit from additional non-invasive or invasive
evaluation.
LIMITATIONS
Several limitations of the present study need to be
considered. First, the present study was a single-centre
34 van den Hoogen et al Journal of Nuclear Cardiology
Prognostic value of coronary CTA in diabetic patients January/February 2016
study. Second, the composite event-rate was relatively
low. As a consequence, the study was underpowered to
include all baseline risk factors into the multivariate
model. Third, the endpoint mainly consisted of late
revascularization; therefore, conclusions regarding hard
endpoints are not justified based on this study. We
cannot rule out that, despite the wide time interval, some
referral bias has occurred in the patients who underwent
late revascularization. Moreover, it is possible that
events that have occurred in other medical centres were
missed in the analysis. Fourth, coronary CTA only
visualizes coronary atherosclerosis and provides no
information on the hemodynamic significance of coro-
nary stenosis.
CONCLUSION
Coronary CTA provided prognostic value in a
large prospective registry of diabetic patients without
chest pain syndrome. Most importantly, the prognosis
of patients with a normal CTA was excellent. In
addition, an incremental increase in event-rate was
observed with increasing CAC-risk category and coro-
nary stenosis severity. The highest event-rate was
observed in patients with severe CAD ([70%). Both
CAC-score and coronary stenosis severity were inde-
pendently predictive of events, after correction for
baseline risk factors.
NEW KNOWLEDGE GAINED
Coronary CTA can be of clinical value for risk
stratification of patients with diabetes mellitus without
chest pain syndrome. Especially, event-free survival is
excellent in patients without coronary artery disease.
The prognostic value of coronary CTA seems to
outweigh the prognostic value of the coronary calcium
score.
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